| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 01/30/2013 | CN101939021B Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 01/30/2013 | CN101780124B Capparis acutifolia sweet exact and preparation method and application thereof |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/24/2013 | US20130023524 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023488 Methods and compounds for reducing intracellular lipid storage |
| 01/24/2013 | US20130023480 Purified Bowman-Birk Protease Inhibitor Proteins Isolated from a Soy Processing Sttream |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022543 Method for Treating and Confirming Diagnosis of Exertional Compartment Syndrome |
| 01/23/2013 | EP2548554A1 Inhibitor of in vivo proteolysis |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102885794A Buccal interferon tablet and preparation method thereof |
| 01/23/2013 | CN102319215B Vecuronium bromide liposome injection |
| 01/23/2013 | CN101210244B Neutrokine-alpha and Neutrokine-alpha splice variants |
| 01/17/2013 | WO2013007663A1 2-benzylsulfanyl[1,3,4]-oxadiazole derivatives, and medical use thereof |
| 01/17/2013 | WO2013007003A1 Novel use of acetylacetic acid for regulating proliferation of skeletal-muscle cells |
| 01/17/2013 | US20130018102 Nutritional supplement for the enhancement of muscle performance and recovery |
| 01/17/2013 | US20130018076 Trigonelline as a muscle stimulant |
| 01/17/2013 | US20130018070 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/17/2013 | US20130018036 Substituted indazole derivatives active as kinase inhibitors |
| 01/17/2013 | US20130018034 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
| 01/17/2013 | US20130018017 Quinolinone derivatives as parp and tank inhibitors |
| 01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
| 01/17/2013 | US20130017280 Composition for accelerating change in muscle type |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
| 01/17/2013 | US20130017190 Treatment of inflammatory diseases |
| 01/17/2013 | CA2849213A1 Combination als therapy |
| 01/16/2013 | EP2546269A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 01/16/2013 | EP2546266A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 01/16/2013 | CN102875642A Compounds for enzyme inhibition |
| 01/16/2013 | CN102872429A Formula of traditional Chinese medicine for treating shaking palsy caused by wind phlegm fire |
| 01/16/2013 | CN102872348A Formula of traditional Chinese medicine for treating shaking palsy caused by qi and blood deficiency |
| 01/16/2013 | CN102872340A External-use honeysuckle-dull leaf powder for treating temporomandibular disorders |
| 01/16/2013 | CN102872320A Formula of traditional Chinese medicine for treating shaking palsy caused by enterohepatic yin deficiency |
| 01/16/2013 | CN102872297A Tablets for tonifying kidney and replenishing essence |
| 01/16/2013 | CN102872291A Medicament for treating muscular soreness |
| 01/16/2013 | CN102872239A Qi-tonifying and yang-raising tablets |
| 01/16/2013 | CN102872237A Skunk bugbane spleen-qi raising tablet |
| 01/16/2013 | CN102871981A Tablet medicine compound containing levetiracetam |
| 01/16/2013 | CN102154301B Preparation and application of conotoxin striatus S21a in South China Sea |
| 01/16/2013 | CN101411876B Neurotoxic oligomers |
| 01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/15/2013 | US8354395 Method for providing neuroprotection from spinal muscular atrophy |
| 01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012565 4-hydroxybutyric acid analogs |
| 01/10/2013 | US20130012537 3,8-diaminotetrahydroquinoline derivative |
| 01/10/2013 | US20130012509 Novel anxiolytic compounds |
| 01/10/2013 | US20130011504 Method for treatment of esophageal spasm |
| 01/10/2013 | US20130011412 Antibodies to lymphotoxin-alpha |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011398 Serpin Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | CA2840222A1 Compositions and methods for treating skeletal myopathy |
| 01/09/2013 | EP2543382A1 Agent for preventing muscular atrophy |
| 01/09/2013 | EP2542539A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 01/09/2013 | CN202653713U Medicine pad |
| 01/09/2013 | CN102869373A Albumin-free botulinum toxin formulations |
| 01/09/2013 | CN102863432A Modulators of cftr |
| 01/09/2013 | CN102861300A Traditional Chinese medicine for treating diaphragm spasm |
| 01/09/2013 | CN102861133A Method for extracting kavalactones by using subcritical water |
| 01/09/2013 | CN102861120A Method for extracting alkaloid from fructus nandinae domesticae |
| 01/09/2013 | CN102860980A Method for preparing rocuronium bromide injection |
| 01/08/2013 | CA2614345C Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
| 01/08/2013 | CA2585560C Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 01/08/2013 | CA2578302C Composition and method for inducing or restoring locomotor functions in an animal |
| 01/08/2013 | CA2521987C Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2485081C Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2447671C Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 01/03/2013 | WO2013003641A2 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | WO2013003593A1 Methods of use of hsp70 for increased performance or hsp70 related disorders |
| 01/03/2013 | WO2013002248A1 Phosphoric acid ester derivative |
| 01/03/2013 | US20130006182 Pharmaceutical compositions |
| 01/03/2013 | US20130005801 Phenylcarbamate compound and muscle relaxant containing the same |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005764 Quinine dosage forms and methods of use thereof |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130004583 Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use |
| 01/03/2013 | US20130004546 Hydrogel of microspheres |
| 01/03/2013 | US20130004491 Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents |
| 01/03/2013 | US20130004466 Myogenic differentiation of stem cells and and uses thereof |
| 01/03/2013 | US20130004465 Adherent cells from placenta and use of same in disease treatment |
| 01/03/2013 | US20130004464 Multipotent adult stem cell population |
| 01/03/2013 | US20130004428 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | CA2831154A1 Use of pertussis toxin as a therapeutic agent |
| 01/02/2013 | EP2538958A1 Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy |
| 01/02/2013 | CN102858751A Cysteine protease inhibitors |
| 01/02/2013 | CN102850436A Growth hormone releasing peptides |
| 01/02/2013 | CN102850324A Indole compounds |
| 01/02/2013 | CN102847138A Medicine composition containing muscular amino acid and nucleoside compound and preparation method thereof |
| 01/02/2013 | CN102847136A Composition for enzyme inhibition |
| 01/02/2013 | CN102847009A A Chinese medicinal formulation for treating singultus |
| 01/02/2013 | CN102846953A Processing method of Anoectochilus roxburghii decoction pieces |
| 01/02/2013 | CN102846952A Method for processing anoectochilus roxburghii purely-fragrant decoction piece |
| 01/02/2013 | CN102846787A Jinsuo spermatorrhea treating capsules |
| 01/02/2013 | CN102846721A Method for supercritical CO2 extraction of Kavalactones |
| 01/02/2013 | CN101830889B 嘧啶衍生物 Pyrimidine derivatives |